SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative
Test Code
To meet regulatory reporting requirements for COVID-19 testing, the patient's address, phone number and other demographic details are required for this order.
Clinical Significance
SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative - This test is intended as an aid in identifying individuals with antibodies to SARS-CoV-2. A positive result indicates an immune response to a recent or prior infection with SARS-CoV-2. This test would not be expected to detect an immune response to a spike vaccine. It is unknown for how long antibodies persist following infection or if the presence of antibodies confers protective immunity. This assay should not be used to diagnose acute SARS-CoV-2 infection.
Test Resources
Test Details
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
1 mL serum
Alternative Specimen(s)
Frozen serum in a plastic transport vial
Minimum Volume
0.5 mL
Collection Instructions
Do not freeze whole blood or any samples stored in a primary tube
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 4 days
- Refrigerated: 7 days
- Frozen: 30 days
Reject Criteria
Gross hemolysis • Grossly lipemic • Grossly icteric • Frozen serum separator tube (SST)
Setup Schedule
Refrigerated: 7 days
Frozen: 30 days